|
US4069819A
(en)
|
1973-04-13 |
1978-01-24 |
Societa Farmaceutici S.P.A. |
Inhalation device
|
|
JPS61140520A
(ja)
|
1984-12-12 |
1986-06-27 |
Lion Corp |
アセチルサリチル酸製剤
|
|
FR2580634B1
(fr)
|
1985-04-19 |
1988-08-05 |
Rhone Poulenc Sante |
Nouveau derive de l'acide acetylsalicylique, sa preparation et les compositions pharmaceutiques qui le contiennent
|
|
DE3814856A1
(de)
|
1988-05-02 |
1989-11-16 |
Verla Pharm |
Mittel zur prophylaxe des herzinfarkts und zur verhuetung des reinfarkts
|
|
IT1228459B
(it)
|
1989-02-23 |
1991-06-19 |
Phidea S R L |
Inalatore con svuotamento regolare e completo della capsula.
|
|
US5327883A
(en)
|
1991-05-20 |
1994-07-12 |
Dura Pharmaceuticals, Inc. |
Apparatus for aerosolizing powdered medicine and process and using
|
|
US20070117862A1
(en)
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US5533502A
(en)
|
1993-05-28 |
1996-07-09 |
Vortran Medical Technology, Inc. |
Powder inhaler with aerosolization occurring within each individual powder receptacle
|
|
US5875776A
(en)
|
1996-04-09 |
1999-03-02 |
Vivorx Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
DE69935154T2
(de)
|
1998-11-12 |
2007-10-25 |
Inc. Transave |
Inhalationssystem
|
|
AU756852B2
(en)
|
1998-11-13 |
2003-01-23 |
Jagotec Ag |
Dry powder for inhalation
|
|
US20030176421A1
(en)
|
1999-12-30 |
2003-09-18 |
Watson John W. |
Prokinetic agents for treating gastric hypomotility and related disorders
|
|
US7089934B2
(en)
|
2000-02-28 |
2006-08-15 |
Vectura Limited |
Delivery of oral drugs
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
GB0010709D0
(en)
|
2000-05-03 |
2000-06-28 |
Vectura Ltd |
Powders for use a in dry powder inhaler
|
|
EP1177805A1
(en)
|
2000-07-31 |
2002-02-06 |
Maryland Financial Inc. |
Powder inhaler
|
|
US6613308B2
(en)
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
NZ526059A
(en)
|
2000-11-30 |
2005-05-27 |
Vectura Ltd |
Method of making composite active particles in the presence of an additive material for use in a pharmaceutical composition
|
|
RU2003122515A
(ru)
|
2000-12-22 |
2005-01-27 |
Эспен Аэроджелз, Инк. (Us) |
Порошок аэрогеля, включающий терапевтические средства
|
|
ATE255929T1
(de)
|
2001-03-05 |
2003-12-15 |
Ivo Pera |
Inhalationsvorrichtung zum dispergieren von in kapseln enthaltenen pulverförmigen medikamente durch den respirationstrakt
|
|
US20060293217A1
(en)
|
2001-03-19 |
2006-12-28 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained release
|
|
US20040049022A1
(en)
|
2001-04-24 |
2004-03-11 |
Nyce Jonathan W. |
Composition & methods for treatment and screening
|
|
GB0129270D0
(en)
|
2001-12-06 |
2002-01-23 |
Pfizer Ltd |
Pharmaceutical combination
|
|
GB0129397D0
(en)
|
2001-12-07 |
2002-01-30 |
Pfizer Ltd |
Pharmaceutical combination
|
|
WO2003072080A1
(en)
|
2002-02-22 |
2003-09-04 |
Advanced Inhalation Research, Inc. |
Inhalable formulations for sustained release
|
|
US7405207B2
(en)
|
2002-06-17 |
2008-07-29 |
Epigenesis Pharmaceuticals, Inc. |
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
AU2003276131A1
(en)
|
2002-06-18 |
2003-12-31 |
Epigenesis Pharmaceuticals, Inc. |
A dry powder oligonucleotide formulation, preparation and its uses
|
|
WO2004030659A1
(en)
|
2002-09-30 |
2004-04-15 |
Acusphere, Inc. |
Sustained release porous microparticles for inhalation
|
|
GB0226105D0
(en)
|
2002-11-08 |
2002-12-18 |
St Georges S Entpr Ltd |
Pain relief agents
|
|
US7516741B2
(en)
|
2002-12-06 |
2009-04-14 |
Novartis Ag |
Aerosolization apparatus with feedback mechanism
|
|
SE0203687D0
(sv)
|
2002-12-13 |
2002-12-13 |
Ian Harwigsson Med Adagit Fa |
Pharmaceutical Porous Particles
|
|
EP1622625A1
(en)
|
2003-04-09 |
2006-02-08 |
Wyeth |
Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo [5.2.o] non-1 (7)-en-2-yl )alkyl] phosphonic acid and derivatives and methods of use thereof
|
|
US7559325B2
(en)
*
|
2003-04-09 |
2009-07-14 |
Novartis Pharma Ag |
Aerosolization apparatus with air inlet shield
|
|
GB0312419D0
(en)
|
2003-05-30 |
2003-07-02 |
Boots Healthcare Int Ltd |
Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
|
|
SE527069C2
(sv)
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
|
US7041286B2
(en)
|
2003-07-23 |
2006-05-09 |
Nerenberg Arnold P |
Composition for mitigating a pernicious thrombotic event
|
|
JP2007502815A
(ja)
|
2003-08-20 |
2007-02-15 |
イーライ リリー アンド カンパニー |
Ｐｐａｒ調節因子
|
|
CA2536293A1
(en)
|
2003-08-22 |
2005-03-03 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating copd and pulmonary hypertension
|
|
US20050249697A1
(en)
|
2003-09-24 |
2005-11-10 |
Uhrich Kathryn E |
Compositions and methods for the inhibition of bone growth and resorption
|
|
JP2011168615A
(ja)
*
|
2003-10-16 |
2011-09-01 |
Daiichi Sankyo Healthcare Co Ltd |
サリチル酸類含有経口組成物
|
|
WO2005040163A1
(en)
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
|
WO2005041886A2
(en)
|
2003-10-31 |
2005-05-12 |
Metaphore Pharmaceuticals, Inc. |
Methods for generating or increasing revenues related to pain inhibitor commerce
|
|
US20070232575A1
(en)
|
2004-02-05 |
2007-10-04 |
Baulieu Etienne E |
Treatment of Pulmonary Artery Hypertension with Dhea, Dheas, Dhea Analogs, or Dhea Derivatives
|
|
EP1722767A2
(en)
|
2004-02-23 |
2006-11-22 |
Prolexys Pharmaceuticals, Inc. |
NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF
|
|
CN1950333A
(zh)
|
2004-05-04 |
2007-04-18 |
辉瑞大药厂 |
取代的甲基芳基或杂芳基酰胺化合物
|
|
US7189750B2
(en)
|
2004-05-05 |
2007-03-13 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof
|
|
MXPA06012980A
(es)
|
2004-05-10 |
2007-06-12 |
Nastech Pharm Co |
Composiciones y metodos para el suministro mucosal mejorado de la hormona paratiroidea.
|
|
WO2006017354A1
(en)
|
2004-07-13 |
2006-02-16 |
Pharmacofore, Inc. |
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing disease or pain
|
|
EP1819329A2
(en)
|
2004-08-04 |
2007-08-22 |
Schering Corporation |
Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
|
|
CA2584971C
(en)
|
2004-11-02 |
2013-08-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for inhibition of nkt cells
|
|
GB0425758D0
(en)
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
|
GB0426301D0
(en)
*
|
2004-11-30 |
2004-12-29 |
Vectura Ltd |
Pharmaceutical formulations
|
|
CA2611741A1
(en)
*
|
2005-06-13 |
2006-12-28 |
Elan Pharma International, Limited |
Nanoparticulate clopidogrel and aspirin combination formulations
|
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
|
US20090220435A1
(en)
|
2005-07-27 |
2009-09-03 |
Nastech Pharmaceutical Company Inc. |
Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents
|
|
JP2009504805A
(ja)
|
2005-08-09 |
2009-02-05 |
ナノバイオ コーポレーション |
抗炎症活性を有するナノエマルジョン組成物
|
|
ITMI20051999A1
(it)
|
2005-10-21 |
2007-04-22 |
Eratech S R L |
Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
|
|
WO2007070851A2
(en)
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
CA2633380A1
(en)
|
2005-12-16 |
2007-07-05 |
University Of Kansas |
Nanoclusters for delivery of therapeutics
|
|
WO2007072503A2
(en)
|
2005-12-21 |
2007-06-28 |
Panacea Biotec Ltd. |
Combinations for managing inflammation and associated disorders
|
|
KR101501780B1
(ko)
|
2006-01-24 |
2015-03-16 |
넥스바이오, 인코퍼레이티드 |
고분자 미소 구체들의 조제를 위한 기술
|
|
GB0605723D0
(en)
|
2006-03-23 |
2006-05-03 |
3M Innovative Properties Co |
Powder filling processes
|
|
EP3669878A1
(en)
|
2006-08-10 |
2020-06-24 |
Roy C. Levitt |
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
|
|
GB0617171D0
(en)
|
2006-08-31 |
2006-10-11 |
Generics Uk Ltd |
Novel compositions and methods
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
US7833527B2
(en)
|
2006-10-02 |
2010-11-16 |
Amgen Inc. |
Methods of treating psoriasis using IL-17 Receptor A antibodies
|
|
GB0621957D0
(en)
|
2006-11-03 |
2006-12-13 |
Vectura Group Plc |
Inhaler devices and bespoke pharmaceutical compositions
|
|
GB0700839D0
(en)
|
2007-01-17 |
2007-02-21 |
Braithwaite Philip |
Device
|
|
EP1964564A1
(en)
|
2007-04-19 |
2008-09-03 |
LAB International SRL |
Breakthrough Pain Management
|
|
US8530463B2
(en)
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
US20110008356A1
(en)
|
2007-06-13 |
2011-01-13 |
Amgen, Inc. |
Il-17 heteromeric receptor complex
|
|
US20090110679A1
(en)
|
2007-07-13 |
2009-04-30 |
Luk-Chiu Li |
Methods and compositions for pulmonary administration of a TNFa inhibitor
|
|
JP2010534563A
(ja)
|
2007-07-24 |
2010-11-11 |
ネクスバイオ，インク． |
マイクロ粒子の作製のための技術
|
|
WO2009019598A2
(en)
*
|
2007-08-03 |
2009-02-12 |
Dr. Reddy's Laboratories Ltd. |
Inhalation therapy for respiratory disorders
|
|
WO2009026434A1
(en)
|
2007-08-21 |
2009-02-26 |
Alkermes, Inc. |
Pulmonary pharmaceutical formulations
|
|
US9358242B2
(en)
|
2007-08-30 |
2016-06-07 |
Prelief Inc. |
Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
|
|
US20110142914A1
(en)
|
2007-12-06 |
2011-06-16 |
Cytotech Labs, Llc |
Inhalable compositions having enhanced bioavailability
|
|
WO2009086470A2
(en)
|
2007-12-27 |
2009-07-09 |
Aires Pharmaceuticals, Inc. |
Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
|
|
DE102008004386A1
(de)
|
2008-01-14 |
2009-07-23 |
Activaero Gmbh |
Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
|
|
MX2010007755A
(es)
|
2008-01-15 |
2010-12-21 |
Univ Strasbourg |
Sintesis de lactonas de acido resorcilico utiles como agentes terapeuticos.
|
|
WO2009136976A2
(en)
|
2008-02-21 |
2009-11-12 |
Amgen Inc |
Il-17ra-il-17rb antagonists and uses thereof
|
|
JP2011512406A
(ja)
|
2008-02-22 |
2011-04-21 |
ハナル バイオファーマ カンパニー リミテッド |
複合製剤
|
|
GB0803369D0
(en)
|
2008-02-25 |
2008-04-02 |
Helperby Therapeutics Ltd |
Biological materials and uses thereof
|
|
MX2010010877A
(es)
|
2008-04-04 |
2010-10-26 |
Irm Llc |
Compuestos y composiciones como inhibidores de itpkb.
|
|
EP2265124A4
(en)
|
2008-04-15 |
2011-12-28 |
Sarcode Bioscience Inc |
AEROSOLISED LFA-1 ANTAGONISTS FOR THE USE IN THE LOCAL TREATMENT OF IMMUNE DISEASES
|
|
WO2009140128A2
(en)
|
2008-05-13 |
2009-11-19 |
Irm Llc |
Compounds and compositions as kinase inhibitors
|
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
|
WO2010009028A1
(en)
|
2008-07-15 |
2010-01-21 |
Schering Corporation |
Intranasal compositions comprising a decongestant and a corticosteroid
|
|
JP5936353B2
(ja)
|
2008-07-18 |
2016-06-22 |
プロソニックス リミテッドＰｒｏｓｏｎｉｘ Ｌｉｍｉｔｅｄ |
フルチカゾン粒子の結晶化度を改善する方法
|
|
WO2010011329A2
(en)
|
2008-07-23 |
2010-01-28 |
Map Pharmaceuticals, Inc. |
The delivery of powdered drug via inhalation
|
|
US8236786B2
(en)
|
2008-08-07 |
2012-08-07 |
Pulmagen Therapeutics (Inflammation) Limited |
Respiratory disease treatment
|
|
JP6002385B2
(ja)
|
2008-09-12 |
2016-10-05 |
クリティカル ファーマシューティカルズ リミテッドＣｒｉｔｉｃａｌ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ |
医薬組成物、医薬組成物における吸収促進剤の使用方法、及び医薬組成物の製造方法
|
|
WO2010103384A1
(en)
|
2009-03-13 |
2010-09-16 |
Nucitec S.A. De C.V. |
Compositions and methods for treatment and prevention of cardiovascular disease
|
|
US20120046251A1
(en)
|
2009-04-06 |
2012-02-23 |
The Regents Of The University Of California |
Inhibitors of soluble epoxide hydrolase to inhibit or prevent niacin-induced flushing
|
|
EP2421867B1
(en)
|
2009-04-20 |
2015-09-02 |
Auspex Pharmaceuticals, Llc |
Piperidine inhibitors of janus kinase 3
|
|
US9101539B2
(en)
|
2009-05-15 |
2015-08-11 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal pharmaceutical compositions with improved pharmacokinetics
|
|
CN102458543B
(zh)
|
2009-05-18 |
2015-02-04 |
3M创新有限公司 |
干粉吸入器
|
|
US9125999B2
(en)
|
2009-05-18 |
2015-09-08 |
Adamis Pharmaceuticals Corporation |
Dry powder inhaler dose counters
|
|
JP2012528844A
(ja)
|
2009-06-01 |
2012-11-15 |
バイオコピア リミテッド |
好中球によって引き起こされる疾患の治療におけるアンレキサノクスの使用
|
|
GB201111485D0
(en)
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
GB0917054D0
(en)
|
2009-09-29 |
2009-11-11 |
Cytoguide As |
Agents, uses and methods
|
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
|
GB0918431D0
(en)
|
2009-10-21 |
2009-12-09 |
Prosonix Ltd |
Process for improving crystallinity
|
|
GB0921481D0
(en)
|
2009-12-08 |
2010-01-20 |
Vectura Ltd |
Process and product
|
|
WO2011127141A1
(en)
|
2010-04-07 |
2011-10-13 |
Abbott Laboratories |
TNF-α BINDING PROTEINS
|
|
AU2011296343B2
(en)
|
2010-08-30 |
2015-12-10 |
Pulmatrix Operating Company, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
|
US8883844B2
(en)
|
2010-09-24 |
2014-11-11 |
Nitrogenix Inc. |
Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
|
|
CN103298470B
(zh)
*
|
2010-09-30 |
2015-06-17 |
奇斯药制品公司 |
硬脂酸镁在吸入用干粉制剂中的用途
|
|
US8561609B2
(en)
|
2010-12-07 |
2013-10-22 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
|
CN102058886A
(zh)
|
2010-12-20 |
2011-05-18 |
云南白药集团无锡药业有限公司 |
医用粉雾剂及其应用
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
GB201102237D0
(en)
|
2011-02-09 |
2011-03-23 |
Kuecept Ltd |
Particle formulation
|
|
KR101862291B1
(ko)
|
2011-04-12 |
2018-05-29 |
모레 매트릭스 인코포레이티드 |
이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정을 예방하거나 치료하기 위한 조성물 및 방법
|
|
US20120306613A1
(en)
|
2011-06-02 |
2012-12-06 |
Nokia Siemens Networks Oy |
Sensor allocation
|
|
US10973763B2
(en)
|
2011-06-17 |
2021-04-13 |
Berg Llc |
Inhalable pharmaceutical compositions
|
|
WO2013016220A1
(en)
|
2011-07-22 |
2013-01-31 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
|
CA2847817A1
(en)
|
2011-09-06 |
2013-03-14 |
Verona Pharma Plc |
Treating cough and tussive attacks
|
|
US9795773B2
(en)
|
2011-12-16 |
2017-10-24 |
Indosys Limited |
Medicament unit dose cartridge and delivery device
|
|
HK1205156A1
(en)
|
2012-01-31 |
2015-12-11 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
EP2819645A2
(en)
*
|
2012-02-28 |
2015-01-07 |
Iceutica Holdings Inc. Bvi |
Inhalable pharmaceutical compositions
|
|
CN107596518B
(zh)
|
2012-02-29 |
2021-04-23 |
普马特里克斯营业公司 |
可吸入干粉剂
|
|
ES2625727T3
(es)
|
2012-03-26 |
2017-07-20 |
Arroyo Biosciences L.L.C. |
Nuevos antagonistas de receptores de esfingosina-1-fosfato
|
|
GB201205632D0
(en)
|
2012-03-30 |
2012-05-16 |
Vectura Ltd |
Method and apparatus
|
|
NZ742005A
(en)
|
2012-05-03 |
2019-04-26 |
Kala Pharmaceuticals Inc |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
SG11201407676VA
(en)
|
2012-05-21 |
2015-03-30 |
Agency Science Tech & Res |
A dry powder formulation
|
|
KR102177557B1
(ko)
|
2012-06-20 |
2020-11-11 |
유니버시티 오브 워터루 |
점막접착성 나노입자의 전달 시스템
|
|
EP2900665B1
(en)
|
2012-09-28 |
2018-01-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
WO2014053482A1
(en)
|
2012-10-03 |
2014-04-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
|
|
WO2014074422A1
(en)
|
2012-11-07 |
2014-05-15 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
|
US9757529B2
(en)
*
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757395B2
(en)
*
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
EP2948148B1
(en)
|
2013-01-28 |
2020-07-29 |
Incozen Therapeutics Pvt. Ltd. |
Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide
|
|
TWI643853B
(zh)
|
2013-02-27 |
2018-12-11 |
阿爾米雷爾有限公司 |
同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
|
|
GB201305813D0
(en)
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
Compositions and methods
|
|
HK1218720A1
(zh)
*
|
2013-04-30 |
2017-03-10 |
欧缇托匹克公司 |
干粉制剂及使用方法
|
|
MX381503B
(es)
|
2013-05-23 |
2025-03-12 |
Aztherapies Inc |
Métodos para la liberación de cromolina.
|
|
TWI641373B
(zh)
|
2013-07-25 |
2018-11-21 |
阿爾米雷爾有限公司 |
具有蕈毒鹼受體拮抗劑和β２腎上腺素受體促效劑二者之活性的２－胺基－１－羥乙基－８－羥基喹啉－２（１Ｈ）－酮衍生物之鹽
|
|
US9925184B2
(en)
|
2013-10-11 |
2018-03-27 |
Pulmokine, Inc. |
Spray-dry formulations
|
|
ES2712129T3
(es)
|
2013-12-23 |
2019-05-09 |
Xiaoguang Wen |
Comprimido de doble capa y método de preparación del mismo
|
|
RU2019119862A
(ru)
|
2014-02-20 |
2019-07-15 |
Аллерган, Инк. |
Антитела к компоненту комплемента c5
|
|
ES2922206T3
(es)
*
|
2014-02-20 |
2022-09-09 |
Otitopic Inc |
Formulaciones de polvo seco para la inhalación
|
|
AU2015223056B2
(en)
|
2014-02-27 |
2020-10-01 |
Allergan, Inc. |
Complement Factor Bb antibodies
|
|
WO2015148415A2
(en)
|
2014-03-26 |
2015-10-01 |
Canget Biotekpharma, Llc |
Use of the fl118 core chemical structure platform to generate fl118 derivatives for treatment of human disease
|
|
EP3126004A4
(en)
|
2014-04-02 |
2017-11-29 |
Rogne Bioscience Inc. |
Methods and compositions for treating inflammatory disorders
|
|
EP3129013A1
(en)
|
2014-04-10 |
2017-02-15 |
Crowley, Patrick |
Delivery of non-steroidal antiinflammatory agents to the brain via the nasal tract to treat neurological disorders
|
|
KR20150127315A
(ko)
|
2014-05-07 |
2015-11-17 |
삼성중공업 주식회사 |
밸러스트수 처리 장치
|
|
ES2942297T3
(es)
*
|
2014-07-31 |
2023-05-31 |
Vectura Inc |
Formulaciones de polvo seco para inhalación
|
|
US20180056022A1
(en)
|
2015-03-21 |
2018-03-01 |
James Zhou Liu |
Hand-actuated dry powder inhaler and its use
|
|
WO2016176552A1
(en)
*
|
2015-04-30 |
2016-11-03 |
Otitopic Inc. |
Dry power formulations for inhalation
|
|
US10568894B2
(en)
*
|
2016-06-03 |
2020-02-25 |
Otitopic Inc. |
Dry powder formulations for inhalation
|
|
CN106619549B
(zh)
*
|
2017-01-03 |
2019-12-06 |
江苏吴中医药集团有限公司苏州制药厂 |
一种替格瑞洛与阿司匹林复合片剂及其制备方法
|
|
KR102681843B1
(ko)
|
2017-09-22 |
2024-07-05 |
벡추라 인코포레이티드 |
스테아르산마그네슘을 갖는 건조 분말 조성물
|
|
US10786456B2
(en)
*
|
2017-09-22 |
2020-09-29 |
Otitopic Inc. |
Inhaled aspirin and magnesium to treat inflammation
|
|
JP7690081B1
(ja)
|
2024-03-14 |
2025-06-09 |
ミサワホーム株式会社 |
モバイルユニットの連結構造
|